Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Open, Randomised, Parallel Group, Noncomparative Multicentre Study to Assess the Efficacy and Safety of Repeated Subcutaneous (S.C.) Administration of Different Doses of BIM 23A760 in Acromegalic Patients

NCT00994214 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00994214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00994214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Open, Randomised, Parallel Group, Noncomparative Multicentre Study to Assess the Efficacy and Safety of Repeated Subcutaneous (S.C.) Administration of Different Doses of BIM 23A760 in Acromegalic Patients
Lead sponsor
Ipsen
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2009
Completion date
February 28, 2011
Enrollment
109 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly